COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries - 15/06/21

Traitements du Covid-19 et effets indésirables associés : le besoin de stratégies effectives pour renforcer le système de pharmacovigilance dans les pays à revenu faible et intermédiaire

Zakir Khan ^1, ⁎ , Yusuf Karataş ^{1, 2}, Hazir Rahman ³, Mughal Qayum ⁴, Khalid Jamaan Alzahrani ⁵, Syed Muhammad Kashif ⁶

¹ Cukurova University, Institute of Health Sciences, Medical Faculty, Department of Pharmacology, Adana, Saricam 01330, Turkey 

² Pharmacovigilance specialist, Medical Faculty, Balcali hospital, Cukurova University, Adana, Saricam 01330, Turkey 

³ Abdul Wali Khan University Mardan (AUKUM), Department of Microbiology, Mardan, Pakistan 

⁴ Kohat University of Science and Technology, Department of Pharmacy, Kohat, Pakistan 

⁵ Taif University, College of Applied Medical Sciences, Department of Clinical Laboratories Sciences, P. O. Box 11099, Taif 21944, Saudi Arabia 

⁶ Dow University of Health Sciences, Department of Medicine, Karachi, Pakistan 

^⁎Zakir Khan, Cukurova University, Institute of Health Sciences, Medical Faculty, Department of Pharmacology, Adana, Saricam 01330, Turkey.Cukurova University, Institute of Health Sciences, Medical Faculty, Department of PharmacologyAdanaSaricam01330Turkey

El texto completo de este artículo está disponible en PDF.